🇺🇸 FDA
Patent

US 11484545

Compounds and methods for treating neurological and cardiovascular conditions

granted A61KA61K31/52A61K31/7076

Quick answer

US patent 11484545 (Compounds and methods for treating neurological and cardiovascular conditions) held by The Board of Regents of the University of Texas System expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/52, A61K31/7076, A61P, A61P25/00